June 24, 2025Starton Therapeutics and Bend Bioscience Enter into Development Agreement for Oral Controlled Release Dosage Form of STAR-LLD (lenalidomide)Read MoreJune 19, 2025BEND BIOSCIENCE OPENS 4 NEW PROCESS DEVELOPMENT & MANUFACTURING SUITES IN OREGONRead MoreApril 2, 2025Bend Bioscience Adds Commercial Spray Drying & Granulation in GeorgiaRead MoreSeptember 4, 2024CoreRx, Societal CDMO, and Bend Bioscience Unite Under the Bend Bioscience BrandRead MoreOctober 17, 2023Bend Bioscience Announces the Opening of its state-of-the-art Pharmaceutical Process and Manufacturing Science FacilityRead More UPCOMING EVENTS Schedule a Meeting June 24, 2025Starton Therapeutics and Bend Bioscience Enter into Development Agreement for Oral Controlled Release Dosage Form of STAR-LLD (lenalidomide)Read MoreJune 19, 2025BEND BIOSCIENCE OPENS 4 NEW PROCESS DEVELOPMENT & MANUFACTURING SUITES IN OREGONRead MoreApril 2, 2025Bend Bioscience Adds Commercial Spray Drying & Granulation in GeorgiaRead MoreSeptember 4, 2024CoreRx, Societal CDMO, and Bend Bioscience Unite Under the Bend Bioscience BrandRead MoreOctober 17, 2023Bend Bioscience Announces the Opening of its state-of-the-art Pharmaceutical Process and Manufacturing Science FacilityRead More
